PMID- 19560272 OWN - NLM STAT- MEDLINE DCOM- 20091117 LR - 20090831 IS - 1872-6623 (Electronic) IS - 0304-3959 (Linking) VI - 145 IP - 1-2 DP - 2009 Sep TI - Experimental arthritis causes tumor necrosis factor-alpha-dependent infiltration of macrophages into rat dorsal root ganglia which correlates with pain-related behavior. PG - 151-9 LID - 10.1016/j.pain.2009.06.002 [doi] AB - After peripheral nerve damage macrophages infiltrate the dorsal root ganglia (DRG) in which cell bodies of lesioned neurons are located. However, infiltration of macrophages into the DRGs was also reported in complete Freund's adjuvant (CFA)-induced inflammation raising the question whether CFA inflammation induces nerve cell damage or whether peripheral inflammation may also trigger macrophage infiltration into DRGs. Related questions are, first, which signals trigger macrophage infiltration into DRGs and, second, is macrophage infiltration correlated with pain-related behavior. Using the rat model of unilateral antigen-induced arthritis (AIA) in the knee we found a massive infiltration of ED1(+) macrophages into the ipsi- and contralateral lumbar DRGs but not into thoracic DRGs. At no time point of AIA DRG neurons showed expression of activating transcription factor-3 (ATF3) indicating that macrophage infiltration is not explainable by nerve cell lesions in this model. During AIA, lumbar but not thoracic DRGs exhibited a bilateral de novo expression of vascular cell adhesion molecule-1 (VCAM-1) which is known to be involved in macrophage infiltration. Tumor necrosis factor-alpha (TNF-alpha) neutralization with etanercept or infliximab treatment after induction of AIA significantly reduced both macrophage infiltration and VCAM-1 expression. It also decreased mechanical hyperalgesia at the inflamed joint although the joint inflammation itself was barely attenuated, and it reduced mechanical hyperalgesia at the non-inflamed contralateral knee joint. Thus, bilateral segment-specific infiltration of macrophages into DRGs is part of an unilateral inflammatory process in peripheral tissue and it may be involved in the generation of hyperalgesia in particular on the non-inflamed side. FAU - Segond von Banchet, Gisela AU - Segond von Banchet G AD - Institute of Physiology I, University Hospital Jena, Germany. Gisela.SegondvonBanchet@mti.uni-jena.de FAU - Boettger, Michael K AU - Boettger MK FAU - Fischer, Nadja AU - Fischer N FAU - Gajda, Mieczyslaw AU - Gajda M FAU - Brauer, Rolf AU - Brauer R FAU - Schaible, Hans-Georg AU - Schaible HG LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090626 PL - United States TA - Pain JT - Pain JID - 7508686 RN - 0 (Activating Transcription Factor 3) RN - 0 (Antibodies) RN - 0 (Atf3 protein, rat) RN - 0 (Ectodysplasins) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0 (Vascular Cell Adhesion Molecule-1) RN - 9007-81-2 (Freund's Adjuvant) SB - IM MH - Activating Transcription Factor 3/metabolism MH - Animals MH - Antibodies/therapeutic use MH - Arthritis, Experimental/chemically induced/*complications/metabolism/pathology MH - Disease Models, Animal MH - Ectodysplasins/metabolism MH - Female MH - Freund's Adjuvant/adverse effects MH - *Ganglia, Spinal/metabolism/pathology/physiopathology MH - Hyperalgesia/*etiology MH - Knee Injuries/etiology MH - Macrophages/*pathology MH - Neutrophil Infiltration/drug effects/physiology MH - Pain Threshold/*physiology MH - Rats MH - Tumor Necrosis Factor-alpha/immunology/*metabolism MH - Vascular Cell Adhesion Molecule-1/metabolism EDAT- 2009/06/30 09:00 MHDA- 2009/11/18 06:00 CRDT- 2009/06/30 09:00 PHST- 2008/11/07 00:00 [received] PHST- 2009/05/06 00:00 [revised] PHST- 2009/06/01 00:00 [accepted] PHST- 2009/06/30 09:00 [entrez] PHST- 2009/06/30 09:00 [pubmed] PHST- 2009/11/18 06:00 [medline] AID - S0304-3959(09)00327-3 [pii] AID - 10.1016/j.pain.2009.06.002 [doi] PST - ppublish SO - Pain. 2009 Sep;145(1-2):151-9. doi: 10.1016/j.pain.2009.06.002. Epub 2009 Jun 26.